litlas
ログインアカウント作成

Jeffrey A. Bluestone

1985–2025 年に発表

280
論文数
86,448
被引用数
158
h 指数
276
i10 指数

被引用数

Jeffrey A. Bluestone の年別被引用数1983 年: 被引用 1 件1985 年: 被引用 1 件1986 年: 被引用 3 件1987 年: 被引用 34 件1988 年: 被引用 113 件1989 年: 被引用 150 件1990 年: 被引用 135 件1991 年: 被引用 112 件1992 年: 被引用 121 件1993 年: 被引用 149 件1994 年: 被引用 141 件1995 年: 被引用 255 件1996 年: 被引用 315 件1997 年: 被引用 326 件1998 年: 被引用 454 件1999 年: 被引用 505 件2000 年: 被引用 439 件2001 年: 被引用 440 件2002 年: 被引用 407 件2003 年: 被引用 388 件2004 年: 被引用 459 件2005 年: 被引用 541 件2006 年: 被引用 578 件2007 年: 被引用 601 件2008 年: 被引用 722 件2009 年: 被引用 824 件2010 年: 被引用 776 件2011 年: 被引用 796 件2012 年: 被引用 776 件2013 年: 被引用 795 件2014 年: 被引用 739 件2015 年: 被引用 842 件2016 年: 被引用 726 件2017 年: 被引用 748 件2018 年: 被引用 852 件2019 年: 被引用 2,263 件2020 年: 被引用 2,574 件2021 年: 被引用 2,639 件2022 年: 被引用 2,348 件2023 年: 被引用 1,840 件2024 年: 被引用 2,521 件2025 年: 被引用 1,236 件2026 年: 被引用 30 件1984 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 10,265 件、この内訳の 34.9%中国: 引用元論文 2,971 件、この内訳の 10.1%イギリス: 引用元論文 1,913 件、この内訳の 6.5%ドイツ: 引用元論文 1,741 件、この内訳の 5.9%フランス: 引用元論文 1,082 件、この内訳の 3.7%日本: 引用元論文 1,081 件、この内訳の 3.7%イタリア: 引用元論文 1,060 件、この内訳の 3.6%カナダ: 引用元論文 994 件、この内訳の 3.4%オーストラリア: 引用元論文 740 件、この内訳の 2.5%オランダ: 引用元論文 659 件、この内訳の 2.2%スイス: 引用元論文 612 件、この内訳の 2.1%スペイン: 引用元論文 484 件、この内訳の 1.6%
0%34.9%その他 19.8%

機関

分野

  • Medicine37.3%
  • Immunology and Microbiology36.2%
  • Biochemistry, Genetics and Molecular Biology22.1%
  • Neuroscience1.8%
  • Engineering0.7%
  • Agricultural and Biological Sciences0.4%
  • その他1.5%

トピック

  • Immune Cell Function and Interaction11.9%
  • T-cell and B-cell Immunology10.9%
  • Immunotherapy and Immune Responses6.6%
  • Cancer Immunotherapy and Biomarkers4%
  • Diabetes and associated disorders3.8%
  • CAR-T cell therapy research3.6%
  • その他59.2%

共著者

全論文

検索で開く
  1. Multiple early factors anticipate post-acute COVID-19 sequelae

    著者: Yapeng Su, Dan Yuan, Daniel Chen, Raymond T. Ng, Kai Wang, Jongchan Choi, Sarah Li, Sunga Hong, Rongyu Zhang, Jingyi Xie, Sergey A. Kornilov, Kelsey Scherler, Ana Jimena Pavlovitch-Bedzyk, Shen Dong, Christopher Lausted, Inyoul Lee, Shannon Fallen, Chengzhen L. Dai, Priyanka Baloni, Brett Smith, Venkata R. Duvvuri, Kristin G. Anderson, Jing Li, Fan Yang, Caroline J. Duncombe, Denise J. McCulloch, Clifford Rostomily, Pamela Troisch, Jing Zhou, Sean Mackay, Quinn DeGottardi, Damon May, Ruth Taniguchi, Rachel Gittelman, Mark Klinger, Thomas M. Snyder, Ryan Roper, Gladys Wojciechowska, Kim M. Murray, Rick Edmark, Simon Evans, Lesley Jones, Yong Zhou, Lee Rowen, Rachel Liu, William Chour, Heather A. Algren, William R. Berrington, Julie A. Wallick, Rebecca A. Cochran, Mary Micikas, Terri Wrin, Christos J. Petropoulos, Hunter Cole, Trevan Fischer, Wei Wei, Dave S.�B. Hoon, Nathan D. Price, Naeha Subramanian, Joshua A. Hill, Jennifer Hadlock, Andrew T. Magis, Antoni Ribas, Lewis L. Lanier, Scott D. Boyd, Jeffrey A. Bluestone, Helen Y. Chu, Leroy Hood, Raphaël Gottardo, Philip D. Greenberg, Mark M. Davis, Jason D. Goldman, James R. Heath - Cell 2022 被引用: 1,220

  2. An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

    著者: Kevan C. Herold, Brian N. Bundy, S. Alice Long, Jeffrey A. Bluestone, Linda A. DiMeglio, Matthew J. Dufort, Stephen E. Gitelman, Peter A. Gottlieb, Jeffrey P. Krischer, Peter S. Linsley, Jennifer B. Marks, Wayne D. Moore, Antoinette Moran, Henry Rodriguez, William E. Russell, Desmond Schatz, Jay S. Skyler, Eva Tsalikian, Diane K. Wherrett, Anette-Gabriele Ziegler, Carla J. Greenbaum - New England Journal of Medicine 2019 被引用: 1,112

  3. Treg cell-based therapies: challenges and perspectives

    著者: Caroline Raffin, Linda T. Vo, Jeffrey A. Bluestone - Nature reviews. Immunology 2019 被引用: 706

  4. CD28 Costimulation: From Mechanism to Therapy

    著者: Jonathan H. Esensten, Ynes Helou, Gaurav Chopra, Arthur Weiss, Jeffrey A. Bluestone - Immunity 2016 被引用: 947

  5. Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis

    著者: Noriko Komatsu, Kazuo Okamoto, Shinichiro Sawa, Tomoki Nakashima, Masatsugu Oh‐hora, Tatsuhiko Kodama, Sakae Tanaka, Jeffrey A. Bluestone, Hiroshi Takayanagi - Nature Medicine 2013 被引用: 1,128

  6. Type 1 diabetes immunotherapy using polyclonal regulatory T cells

    著者: Jeffrey A. Bluestone, Jane H. Buckner, Mark Fitch, Stephen E. Gitelman, Shipra Gupta, Marc K. Hellerstein, Kevan C. Herold, Angela Lares, Michael R. F. Lee, Kelvin Li, Weihong Liu, S. Alice Long, Lisa M. Masiello, Vinh Nguyen, Amy Putnam, Mary Rieck, Peter H. Sayre, Qizhi Tang - Science Translational Medicine 2015 被引用: 1,013

  7. Revisiting IL-2: Biology and therapeutic prospects

    著者: Abul K. Abbas, Eleonora Trotta, Dimitre R. Simeonov, Alexander Marson, Jeffrey A. Bluestone - Science Immunology 2018 被引用: 633

  8. Next-generation regulatory T cell therapy

    著者: Leonardo M. R. Ferreira, Yannick D. Müller, Jeffrey A. Bluestone, Qizhi Tang - Nature Reviews Drug Discovery 2019 被引用: 473

  9. Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis

    著者: James Lee, Sadaf Mehdizadeh, Jennifer Smith, Arabella Young, Ilgiz A. Mufazalov, Cody T. Mowery, Adil Daud, Jeffrey A. Bluestone - Science Immunology 2020 被引用: 300

  10. CTLA-4 can function as a negative regulator of T cell activation

    著者: Theresa L. Walunas, Deborah J. Lenschow, Christina Y. Bakker, Peter S. Linsley, Gordon J. Freeman, Jonathan M. Green, Craig B. Thompson, Jeffrey A. Bluestone - Immunity 1994 被引用: 2,198

  11. Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes

    著者: Jonathan T. Sockolosky, Eleonora Trotta, Giulia Parisi, Lora K. Picton, Leon Su, Alan Le, Akanksha Chhabra, Stephanie Silveria, Benson M. George, Indigo C. King, Matthew Tiffany, Kevin M. Jude, Leah V. Sibener, David Baker, Judith A. Shizuru, Antoni Ribas, Jeffrey A. Bluestone, K. Christopher García - Science 2018 被引用: 373

  12. Control of peripheral T‐cell tolerance and autoimmunity via the CTLA‐4 and PD‐1 pathways

    著者: Brian T. Fife, Jeffrey A. Bluestone - Immunological Reviews 2008 被引用: 1,034

  13. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo

    著者: Xuyu Zhou, Samantha L. Bailey-Bucktrout, Lukas T. Jeker, Cristina Peñaranda, Marc Martínez‐Llordella, Meredith Ashby, Maki Nakayama, Wendy Rosenthal, Jeffrey A. Bluestone - Nature Immunology 2009 被引用: 1,339

  14. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

    著者: Weihong Liu, Amy Putnam, Zhou Xu-yu, Gregory L. Szot, Michael R. Lee, Shirley Zhu, Peter A. Gottlieb, Philipp Kapranov, T Gingeras, Barbara Fazekas de St Groth, Carol Clayberger, David M. Soper, Steven F. Ziegler, Jeffrey A. Bluestone - The Journal of Experimental Medicine 2006 被引用: 2,584

  15. Innate immunity and intestinal microbiota in the development of Type 1 diabetes

    著者: Wen Li, Ruth E. Ley, Pavel Volchkov, P. Benjamin Stranges, Lia Avanesyan, Austin C. Stonebraker, Changyun Hu, F. Susan Wong, Gregory L. Szot, Jeffrey A. Bluestone, Jeffrey I. Gordon, Alexander V. Chervonsky - Nature 2008 被引用: 1,930

  16. Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials

    著者: Birgit Sawitzki, Paul Harden, Petra Reinke, Aurélie Moreau, James A. Hutchinson, David Game, Qizhi Tang, Eva C. Guinan, Manuela Battaglia, William J. Burlingham, Ian S.D. Roberts, Mathias Streitz, Régis Josien, Carsten A. Böger, Cristiano Scottà, James F. Markmann, Joanna Hester, Karsten Juerchott, Cécile Braudeau, Ben James, Laura Contreras‐Ruiz, Jeroen B. van der Net, Tobias Bergler, Rossana Caldara, William Petchey, Matthias Edinger, Nathalie Dupas, Michael Kapinsky, Ingrid Mutzbauer, Natalie Otto, Robert Öllinger, María P. Hernández-Fuentes, Fadi Issa, Norbert Ahrens, Christoph Meyenberg, Sandra Karitzky, Ulrich Kunzendorf, Stuart J. Knechtle, Josep M. Grinyó, Peter J. Morris, L Brent, Andrew Bushell, Laurence A. Turka, Jeffrey A. Bluestone, Robert I. Lechler, Hans J. Schlitt, María Cristina Cuturi, Stephan Schlickeiser, Peter J. Friend, Tewfik Miloud, Alexander Scheffold, Antonio Secchi, Kerry Crisalli, Sang‐Mo Kang, Rachel Hilton, Bernhard Banas, Gilles Blancho, Hans‐Dieter Volk, Giovanna Lombardi, Kathryn J. Wood, Edward K. Geissler - The Lancet 2020 被引用: 451

  17. Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency

    著者: David N. Nguyen, Theodore L. Roth, P. Jonathan Li, Peixin Amy Chen, Ryan Apathy, Murad R. Mamedov, Linda T. Vo, Victoria Tobin, Daniel B. Goodman, Eric Shifrut, Jeffrey A. Bluestone, Jennifer M. Puck, Francis C. Szoka, Alexander Marson - Nature Biotechnology 2019 被引用: 325

  18. Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

    著者: Yapeng Su, Daniel Chen, Dan Yuan, Christopher Lausted, Jongchan Choi, Chengzhen L. Dai, Valentin Voillet, Venkata R. Duvvuri, Kelsey Scherler, Pamela Troisch, Priyanka Baloni, Guangrong Qin, Brett Smith, Sergey A. Kornilov, Clifford Rostomily, Alexander M. Xu, Jing Li, Shen Dong, Alissa C. Rothchild, Jing Zhou, Kim M. Murray, Rick Edmark, Sunga Hong, John E. Heath, John C. Earls, Rongyu Zhang, Jingyi Xie, Sarah Li, Ryan Roper, Lesley Jones, Yong Zhou, Lee Rowen, Rachel Liu, Sean Mackay, D. Shane O’Mahony, Christopher Dale, Julie A. Wallick, Heather A. Algren, Michael Zager, Wei Wei, Nathan D. Price, Sui Huang, Naeha Subramanian, Kai Wang, Andrew T. Magis, Jennifer Hadlock, Leroy Hood, Alan Aderem, Jeffrey A. Bluestone, Lewis L. Lanier, Philip D. Greenberg, Raphaël Gottardo, Mark M. Davis, Jason D. Goldman, James R. Heath - Cell 2020 被引用: 644

  19. CRISPR screen in regulatory T cells reveals modulators of Foxp3

    著者: Jessica T. Cortez, Elena Montauti, Eric Shifrut, Jovylyn Gatchalian, Yusi Zhang, Oren Shaked, Yuanming Xu, Theodore L. Roth, Dimitre R. Simeonov, Yana Zhang, Siqi Chen, Zhongmei Li, Jonathan M. Woo, Josephine Ho, Ian Vogel, Grace Y. Prator, Bin Zhang, Youjin Lee, Zhaolin Sun, Igal Ifergan, Frédéric Van Gool, Diana C. Hargreaves, Jeffrey A. Bluestone, Alexander Marson, Deyu Fang - Nature 2020 被引用: 236

  20. The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes

    著者: Shen Dong, Kamir J. Hiam-Galvez, Cody T. Mowery, Kevan C. Herold, Stephen E. Gitelman, Jonathan H. Esensten, Weihong Liu, Angela Lares, Ashley Leinbach, Michael Lee, Vinh Nguyen, Stanley Tamaki, Whitney Tamaki, Courtney Tamaki, Morvarid Mehdizadeh, Amy Putnam, Matthew H. Spitzer, Chun Ye, Qizhi Tang, Jeffrey A. Bluestone - JCI Insight 2021 被引用: 221

  21. Generation of knock-in primary human T cells using Cas9 ribonucleoproteins

    著者: Kathrin Schumann, Steven Lin, Eric Boyer, Dimitre R. Simeonov, Meena Subramaniam, Rachel E. Gate, Genevieve Haliburton, Chun Ye, Jeffrey A. Bluestone, Jennifer A. Doudna, Alexander Marson - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 被引用: 723

  22. Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity

    著者: David Wang, Jason Quiros, Kelly M. Mahuron, Chien-Chun Steven Pai, Valeria Ranzani, Arabella Young, Stephanie Silveria, Tory Harwin, Arbi Abnousian, Massimiliano Pagani, Michael D. Rosenblum, Frédéric Van Gool, Lawrence Fong, Jeffrey A. Bluestone, Michel DuPage - Cell Reports 2018 被引用: 310

  23. Opportunities for Treg cell therapy for the treatment of human disease

    著者: Jeffrey A. Bluestone, Brent S. McKenzie, Joshua Beilke, Fred Ramsdell - Frontiers in Immunology 2023 被引用: 124

  24. In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes

    著者: Qizhi Tang, Kammi Henriksen, Mingying Bi, Erik B. Finger, Gregory L. Szot, Jianqin Ye, Emma L. Masteller, Hugh O. McDevitt, Mark Bonyhadi, Jeffrey A. Bluestone - The Journal of Experimental Medicine 2004 被引用: 1,214